{
    "Trade/Device Name(s)": [
        "Oral Fluid Cocaine Metabolite (Benzoylecgonine) Homogeneous Enzyme Immunoassay",
        "Calibrators and Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K050945",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001197"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "March 29, 2006",
    "Summary Letter Received Date": "March 10, 2006",
    "Submission Date": "March 8, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system",
        "Drug Specific, Calibrators",
        "Single (Specified) Analyte Controls"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoylecgonine"
    ],
    "Specimen Type(s)": [
        "Saliva"
    ],
    "Specimen Container(s)": [
        "Salivette collector"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Oral Fluid Cocaine Metabolite (Benzoylecgonine) Homogeneous Enzyme Immunoassay, Calibrators and Controls for qualitative cocaine metabolite detection in oral fluid",
    "Indications for Use Summary": "Qualitative detection of cocaine metabolite in human saliva (oral fluid) at a cutoff of 15 ng/mL using Salivette collector, for preliminary drug of abuse testing with confirmatory analysis by GC/MS.",
    "fda_folder": "Toxicology"
}